SCHEMBL652523

SCHEMBL652523

O=C(O)CCC(C(=O)O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.53
CPA3 P15088 1/20 0.52
NAALAD2 Q9Y3Q0 2/20 0.50
CYP2D6 P10635 3/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP1A2 P05177 1/20 0.48
TSHR P16473 1/20 0.48
SRC P12931 1/20 0.46
MAPK1 P28482 2/20 0.46
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
GLA P06280 1/20 0.46
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46
HSD17B10 Q99714 1/20 0.46
LMNA P02545 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27491825 1.00 CYP2C19 (0.53) CYP2C19CPA3NAALAD2CYP2D6ALDH1A1
SCHEMBL28234437 0.98 CYP2C19 (0.52) CYP2C19CPA3NAALAD2CYP2D6ALDH1A1
SCHEMBL10917742 0.91 ALDH1A1 (0.47) CYP2C19CPA3NAALAD2CYP2D6ALDH1A1
SCHEMBL28710491 0.89 MMP9 (0.51) CYP2C19CPA3NAALAD2CYP1A2TSHR
SCHEMBL2878605 0.88 CYP2C19 (0.50) CYP2C19CPA3NAALAD2CYP2D6ALDH1A1
SCHEMBL30371912 0.87 CYP2C19 (0.61) CYP2C19CYP2D6ALDH1A1SRCMAPK1
SCHEMBL14359835 0.86 CYP2C19 (0.53) CYP2C19CPA3NAALAD2CYP2D6ALDH1A1
SCHEMBL1595937 0.85 TBXAS1 (0.55) CYP2C19CYP2D6ALDH1A1CYP1A2TSHR
SCHEMBL14359989 0.85 TBXAS1 (0.55) CYP2C19CYP2D6ALDH1A1CYP1A2TSHR
SCHEMBL6542954 0.85 TBXAS1 (0.55) CYP2C19CYP2D6ALDH1A1CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629668-B2 Method of remanufacturing spent catalyst for heavy oil desulfurization HANSEO UNIVERSITY ACADEMIC COOPERATION FOUNDATION (KR) 2026-05-19 US claimed
EP-3778022-B1 METHOD FOR PREPARING ORGANIC ZINC CATALYST LG CHEMICAL LTD (KR) 2026-04-22 EP claimed
EP-4329709-B1 COMPOSITION COMPRISING DESFERRIOXAMINES AND UV LIGHT FILTER EVONIK OPERATIONS GMBH (DE) 2026-01-28 EP claimed
EP-4637737-A1 COMPOSITIONS CONTAINING BIOSURFACTANTS AND DESFERRIOXAMINES Evonik Operations GmbH (DE) 2025-10-29 EP claimed
EP-4626393-A1 COMPOSITION COMPRISING DESFERRIOXAMINES AND A MIXTURE OF TRIGLYCERIDES Evonik Dr. Straetmans GmbH (DE) 2025-10-08 EP claimed
US-12152173-B2 Composite polyester hot-melt adhesive and preparation method thereof and preparation method of anti-scouring geotextile CHINA INSTITUTE OF WATER RESOURCES AND HYDROPOWER RESEARCH (CN) 2024-11-26 US claimed
US-20240342698-A1 METHOD OF REMANUFACTURING SPENT CATALYST FOR HEAVY OIL DESULFURIZATION HANSEO UNIVERSITY ACADEMIC COOPERATION FOUNDATION (KR) 2024-10-17 US claimed
WO-2024132679-A1 COMPOSITIONS CONTAINING BIOSURFACTANTS AND DESFERRIOXAMINES EVONIK DR. STRAETMANS GMBH (DE) 2024-06-27 WO claimed
US-20240207153-A1 DESFERRIOXAMINES AND COMPOSITION CONTAINING UV LIGHT PROTECTION FILTERS EVONIK DR. STRAETMANS GMBH (DE) 2024-06-27 US claimed
WO-2024115214-A1 COMPOSITION COMPRISING DESFERRIOXAMINES AND A MIXTURE OF TRIGLYCERIDES EVONIK DR. STRAETMANS GMBH (DE) 2024-06-06 WO claimed
US-20140031289-A1 POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-01-30 US claimed
CN-101528865-B Modified colorants with aliphatic poly-acid groups CABOT CORP 2013-01-30 CN claimed
US-8021471-B2 Modified colorants with aliphatic poly-acid groups CABOT CORPORATION (US) 2011-09-20 US claimed
CN-101528865-A Modified colorants with aliphatic poly-acid groups CABOT CORP (US) 2009-09-09 CN claimed
EP-2059565-A2 MODIFIED COLORANTS WITH ALIPHATIC POLY-ACID GROUPS Cabot Corporation (US) 2009-05-20 EP claimed
EP-1916252-B1 Platinum catalyst WACKER CHEMIE AG (DE) 2008-11-05 EP claimed
US-7393966-B2 Process for preparing platinum catalyst WACKER CHEMIE AG (DE) 2008-07-01 US claimed
US-20080103322-A1 PROCESS FOR PREPARING PLATINUM CATALYST WACKER CHEMIE AG (DE) 2008-05-01 US claimed
US-20080083347-A1 Readily dispersible in liquid vehicles; stability; ink jet pigments; quality optical density on plain paper CABOT CORPORATION 2008-04-10 US claimed
WO-2008027405-A2 MODIFIED COLORANTS WITH ALIPHATIC POLY-ACID GROUPS CABOT CORPORATION (US) 2008-03-06 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629668-B2 Method of remanufacturing spent catalyst for heavy oil desulfurization U2AF2, ELOVL1, U2AF1 CYP2C19 522/4885CPA3 3939/4885NAALAD2 1898/4885
US-20140031289-A1 POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF PHOSPHO1, PLCB3, INPP5D CYP2C19 140/4885CPA3 2283/4885NAALAD2 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.